- Home
- SLN
as 11-05-2025 4:00pm EST
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
Upcoming Earnings Alert:
Get ready for potential market movements as Silence Therapeutics Plc American Depository Share SLN prepares to release earnings report on 07 Nov 2025.
| Founded: | 1994 | Country: | United Kingdom |
| Employees: | N/A | City: | LONDON |
| Market Cap: | 345.3M | IPO Year: | N/A |
| Target Price: | $39.67 | AVG Volume (30 days): | 213.8K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.68 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.97 - $18.24 | Next Earning Date: | 11-07-2025 |
| Revenue: | $27,169,000 | Revenue Growth: | 22.28% |
| Revenue Growth (this year): | -25.23% | Revenue Growth (next year): | N/A |
Latest Silence Therapeutics Plc American Depository Share News
SLN Breaking Stock News: Dive into SLN Ticker-Specific Updates for Smart Investing
MT Newswires
7 days ago
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
MT Newswires
14 days ago
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
Business Wire
14 days ago
Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV)
Simply Wall St.
20 days ago
Is Silence Therapeutics (NASDAQ:SLN) In A Good Position To Deliver On Growth Plans?
MT Newswires
22 days ago
European Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading
MT Newswires
24 days ago
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
MT Newswires
a month ago
European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading, Down 2.8% for Week
MT Newswires
a month ago
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
Compare SLN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SLN Silence Therapeutics Plc American Depository Share - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.